SEC Form 4 insider trading filings tracked in real time from EDGAR

Chopas James George — VP/Chief Accounting Officer

Insider trading activity for Chopas James George sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: VP/Chief Accounting Officer
  • Company: Apellis Pharmaceuticals, Inc.
  • Total insider trades: 19
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: May 14, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 21,750 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 12,086 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 15,114 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 20,853 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 11,250 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 6,250 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 16,150 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 9,444 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 4,156 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 2,406 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 8,075 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. BUY 8,075 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 16,150 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. BUY 16,150 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 8,394 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. BUY 8,394 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. SELL 5,625 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. BUY 5,625 N/A
May 14, 2026 Chopas James George APLS Apellis Pharmaceuticals, Inc. OTHER 65,955 N/A

← All executives · Full trades feed